Enasidenib Mesylate
methanesulfonic acid;2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol
Molecular Identity
Enasidenib Mesylate
methanesulfonic acid;2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol
PubChem CID: 90480031
2D Structure
Properties
C20H21F6N7O4S
Molecular Formula
569.50
Molecular Weight
g/mol
569.1280
Exact Mass
Da
171
TPSA
May have limited oral absorption
4
H-Bond Donors
17
H-Bond Acceptors
727
Complexity
SMILES
Canonical SMILES
SMILES: CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O.CS(=O)(=O)OIsomeric SMILES
SMILES: CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O.CS(=O)(=O)OSynonyms(20)
Enasidenib mesylate1650550-25-6AG-221 mesylateEnasidenib mesilateEnasidenib methanesulfonateUNII-UF6PC17XAVUF6PC17XAVCC-900072-Methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol methanesulfonate2-Propanol, 2-methyl-1-((4-(6-(trifluoromethyl)-2-pyridinyl)-6-((2-(trifluoromethyl)-4-pyridinyl)amino)-1,3,5-triazin-2-yl)amino)-, methanesulfonate (1:1)RefChem:58280Enasidenib (mesylate)EnasidenibmesylateEnasidenib mesylate [USAN]SCHEMBL16448052
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Enasidenib Mesylate
Loading drug network...